SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Identix (IDNX) -- Ignore unavailable to you. Want to Upgrade?


To: brad greene who wrote (15696)11/14/1999 7:22:00 PM
From: Caroline and Daughters  Respond to of 26039
 
That has been my worry for eons. We got shafted by Monsanto when they swallowed Calgene. That happened just the quarter before Calgene started showing a profit. I am afraid of the same thing with IDX.
As I have said earlier , I hope Fowler has a special pill for that.
Grunt



To: brad greene who wrote (15696)11/26/1999 1:08:00 PM
From: Jaunatxo  Respond to of 26039
 
Am long on this stock but I will post a Nov 22 Value Line Spec. Situations report dated Nov. 22 it will have to be in two postings, perhaps IDX is beginning to address the points raised, here goes:
" A shortfall in fiscal first ( September) quarter revenues and earnings has led us to reappraise the time frame for IDX potential success. We believe that for the company to succeed, there must widespread adoption of biometric identification in applications such as ATM's and personal computers - as a replacement for the many passwords consumers and customers must regularily deal with. A lot of Identix's current business , however is in providing products and services to govt. agencies with more narrow applications in mind. This is a good intermediate stage for the company, as it provides for further development of its technology before broaching the much wider commercial market. But we feel IDX must acheive acceptance into those much larger markets to ensure long-term success. A recent agreement with Infineon Tech. to develop fingerprint-based biometric solutions for...mass market PC's and other applications is a good example of the diection the Co. must head in to regain a high rate of growth. In the meantime, we are reducing our Recommendation to that of Hold and trimming our three to five yr projections"



To: brad greene who wrote (15696)11/26/1999 1:30:00 PM
From: Jaunatxo  Respond to of 26039
 
Valueline Special Situations Nov. 22 Report Cont. Analysis: " IDX reported fiscal first (September) quarter revenues of $17.5 million-significantly below our estimates and a 16% decrease year-over year. the shortfall was led by a 28% decrease in product sales as biometric imaging sales decreased when govt. orders for live-scan systems were delayed due to spending-authorization cycles. In addition, many state and local governments spent their budgets on other priorities such as upgrading communication networks. Service revenues also decreased as certain contracts were received late in the quarter. As revenues slumped,operating expenses continued to ramp up both year-over year and sequentially. As IDX spends heavily on further R&D and sales and marketing its operating margin dipped well into the red losing 16% of revenues vs. a profit of 3% of revenues a year ago. This excludes a non rec. charge of $885,000(0.03/sh) related to a write down of inventory and intangible assets. accordingly, the fiscal first-quarter bottom line was well below our was also well below our estimate. a share loss of $.11 did not meet our estimate of breaking even and compared unfavorably to earnings of $.02 a share a year ago. " cont.



To: brad greene who wrote (15696)11/26/1999 1:41:00 PM
From: Jaunatxo  Read Replies (1) | Respond to of 26039
 
Valueline Special Situations report Nov. 22 Conclusion
" The success of IDX depends on the widespread adoption of its technology as a workaday replacement for computer users' myriad passwords. As long as its product sales are limited to govt. and law enforcement agencies as well as high-end computer systems, the timing and magnitude of its sales growth will remain unpredictable. We are reducing our estimates for fiscal 2000 until the company can manifest the jump to widespread consumer use that we envisioned when recommending IDX. Our current estimates for fiscal 2000 call for revenues of $80 million and a share loss of $0.20. D.J.H"